Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$2.5 million.

  • Bioharvest Sciences' Income from Continuing Operations rose 654.52% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year decrease of 33640.71%. This contributed to the annual value of -$12.9 million for FY2024, which is 277.78% down from last year.
  • Bioharvest Sciences' Income from Continuing Operations amounted to -$2.5 million in Q3 2025, which was up 654.52% from -$4.1 million recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Income from Continuing Operations peaked at $7.2 million during Q4 2023, and registered a low of -$6.6 million during Q1 2024.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$2.4 million (2025), whereas its average is -$1.0 million.
  • The largest annual percentage gain for Bioharvest Sciences' Income from Continuing Operations in the last 5 years was 6447.35% (2025), contrasted with its biggest fall of 49388.65% (2025).
  • Quarter analysis of 3 years shows Bioharvest Sciences' Income from Continuing Operations stood at $7.2 million in 2023, then tumbled by 140.75% to -$2.9 million in 2024, then increased by 14.76% to -$2.5 million in 2025.
  • Its last three reported values are -$2.5 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.3 million during Q1 2025.